MyAverix Finance
HK · Healthcare
Shanghai Henlius Biotech Inc (2696)
Biotechnology
Shanghai Henlius Biotech Inc (2696) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $38.13B, P/E ratio is 40.32, net margin is 12.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2696
Shanghai Henlius Biotech Inc (2696) — FAQ
What is Shanghai Henlius Biotech Inc's market cap?
Shanghai Henlius Biotech Inc (2696) has a reported market cap of $38.13B (data as of 2026-05-21).
What is 2696's P/E ratio?
The price-to-earnings (P/E) ratio for Shanghai Henlius Biotech Inc (2696) is 40.32 (data as of 2026-05-21).
Does Shanghai Henlius Biotech Inc pay a dividend?
Dividend yield is not available in the current snapshot for Shanghai Henlius Biotech Inc (2696). Check the MyAverix Finance app for the latest dividend data.
What sector is Shanghai Henlius Biotech Inc in?
Shanghai Henlius Biotech Inc (2696) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 2696 listed on?
2696 is listed on HK.
What is Shanghai Henlius Biotech Inc's net margin?
Shanghai Henlius Biotech Inc (2696) reports a net margin of 12.4% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.